Protara Therapeutics Stock Analysis

Protara Stock Analysis Notes

About 87.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Protara Therapeutics recorded a loss per share of 2.17. The entity last dividend was issued on the 10th of January 2020. The firm had 1:40 split on the 10th of January 2020. Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. Protara Therapeutics, Inc. is headquartered in New York, New York. Artara Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 31 people. To find out more about Protara Therapeutics contact the company at 646 844 0337 or learn more at https://www.protaratx.com.

Protara Therapeutics Investment Alerts

Protara Therapeutics Upcoming and Recent Events

Protara Largest EPS Surprises

View All Earnings Estimates

Protara Therapeutics Environmental, Social, and Governance (ESG) Scores

Protara Stock Institutional Investors

Note, although Protara Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Protara Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 172.81 M.

Protara Profitablity

Management Efficiency

Protara Therapeutics has return on total asset (ROA) of (0.236) % which means that it has lost $0.236 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3788) %, meaning that it created substantial loss on money invested by shareholders. Protara Therapeutics' management efficiency ratios could be used to measure how well Protara Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of March 25, 2025, Return On Tangible Assets is expected to decline to -0.26. In addition to that, Return On Capital Employed is expected to decline to -0.3. At present, Protara Therapeutics' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 1.2 M, whereas Total Assets are forecasted to decline to about 102 M.

Technical Drivers

As of the 25th of March, Protara Therapeutics holds the Coefficient Of Variation of (3,503), variance of 22.64, and Risk Adjusted Performance of (0.02). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Protara Therapeutics, as well as the relationship between them.

Protara Therapeutics Price Movement Analysis

Protara Therapeutics Insider Trading Activities

Protara Therapeutics Outstanding Bonds

Protara Therapeutics Predictive Daily Indicators

Protara Therapeutics Corporate Filings

Protara Therapeutics Forecast Models

Protara Therapeutics' time-series forecasting models are one of many Protara Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Protara Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Protara Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Protara shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Protara Therapeutics. By using and applying Protara Stock analysis, traders can create a robust methodology for identifying Protara entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Protara analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Protara analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Protara Therapeutics stock analysis indicators help investors evaluate how Protara Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Protara Therapeutics shares will generate the highest return on investment. By understating and applying Protara Therapeutics stock analysis, traders can identify Protara Therapeutics position entry and exit signals to maximize returns.

When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.